Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Eur Heart J
    June 2021
  1. VOLPE M, Patrono C
    The increased mortality of STEMI patients without risk factors supports the need for evidence-based pharmacotherapy irrespective of perceived low risk.
    Eur Heart J. 2021;42:2329-2330.
    >> Share

  2. CREA F
    The Universal Definition of Heart Failure, risk prediction in cardiogenic shock, artificial intelligence in cardiac allograft rejection, and the genetics of dilated cardiomyopathy.
    Eur Heart J. 2021;42:2317-2320.
    >> Share

  3. HUBER K
    Scores for outcome prediction in patients admitted with cardiogenic shock.
    Eur Heart J. 2021;42:2353-2355.
    >> Share

  4. LUSEBRINK E, Massberg S, Orban M
    The multiple options of left atrial and ventricular venting during veno-arterial extra-corporeal membrane oxygenation: practical considerations.
    Eur Heart J. 2021;42:2399-2400.
    >> Share

  5. POZZI M, Grinberg D, Rioufol G
    Percutaneous left ventricular unloading in veno-arterial extracorporeal membrane oxygenation.
    Eur Heart J. 2021;42:2397-2398.
    >> Share

  6. VOLPE M, Patrono C
    Vulnerable non-culprit coronary plaques: are they worth treating?
    Eur Heart J. 2021;42:2233-2234.
    >> Share

  7. COLLET JP, Thiele H
    Major bleeding and the ADP-binding enzyme creatine kinase in non-ST-segment elevation acute coronary syndromes.
    Eur Heart J. 2021;42:2313-2314.
    >> Share

  8. BREWSTER LM
    Because of its association with major bleeding the ADP-binding enzyme creatine kinase should be estimated in studies of patients treated for non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
    Eur Heart J. 2021;42:2311-2312.
    >> Share

    May 2021
  9. VARBO A, Nordestgaard BG
    Directly measured vs. calculated remnant cholesterol identifies additional overlooked individuals in the general population at higher risk of myocardial infarction.
    Eur Heart J. 2021 May 23. pii: 6282433. doi: 10.1093.
    >> Share

  10. VAN DER STOUWE JG, Boeddinghaus J, Mueller C
    Long-term beta-blocker treatment in stable patients after myocardial infarction: a potential impact due to changes in the diagnosis of myocardial infarction?
    Eur Heart J. 2021 May 23. pii: 6282428. doi: 10.1093.
    >> Share

  11. HOLT A, Blanche P, McGettigan P, Lamberts M, et al
    Temporal changes in myocardial infarction diagnostic criteria do not account for the lack of long-term beta-blocker effect on cardiovascular prognosis.
    Eur Heart J. 2021 May 23. pii: 6282429. doi: 10.1093.
    >> Share


  12. Corrigendum to: Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials.
    Eur Heart J. 2021 May 23. pii: 6282430. doi: 10.1093.
    >> Share

    April 2021
  13. JANSEN TPJ, Damman P, Nijveldt R
    Diagnostic necessity of cardiac MRI in myocardial infarction with no obstructive coronary arteries: an illustration.
    Eur Heart J. 2021 Apr 14. pii: 6225950. doi: 10.1093.
    >> Share

  14. CREA F
    Guidelines on myocardial infarction, novel therapeutic targets in post-infarction remodelling, and a debate on the ISCHEMIA trial.
    Eur Heart J. 2021;42:1277-1280.
    >> Share

  15. BODEN WE, Stone PH
    To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
    Eur Heart J. 2021;42:1394-1400.
    >> Share

  16. GERSH BJ, Boden WE, Bhatt DL, Stone PH, et al
    To stent or not to stent? Treating angina after ISCHEMIA-introduction.
    Eur Heart J. 2021;42:1387-1388.
    >> Share

  17. GERSH BJ, Bhatt DL
    To stent or not to stent? Treating angina after ISCHEMIA-the impact of the ISCHEMIA trial on the indications for angiography and revascularization in patients with stable coronary artery disease.
    Eur Heart J. 2021;42:1389-1393.
    >> Share

  18. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
    The association between coronary graft patency and clinical status in patients with coronary artery disease.
    Eur Heart J. 2021;42:1433-1441.
    >> Share

  19. RADICO F, Zimarino M, De Caterina R
    Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?
    Eur Heart J. 2021;42:1444-1445.
    >> Share

  20. SCHRODER J, Prescott E
    Coronary flow velocity reserve adds prognostic information beyond presence or absence of non-obstructive coronary atherosclerosis.
    Eur Heart J. 2021;42:1442-1443.
    >> Share

  21. SECHTEM U, Ong P
    Coronary stenoses in patients suspected to have obstructive coronary artery disease: the exemption rather than the rule!
    Eur Heart J. 2021;42:1412-1414.
    >> Share

  22. WINTHER S, Schmidt SE, Rasmussen LD, Juarez Orozco LE, et al
    Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease.
    Eur Heart J. 2021;42:1401-1411.
    >> Share

  23. COLLET JP, Thiele H, Barbato E, Barthelemy O, et al
    2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1289-1367.
    >> Share

  24. BARBATO E, Mehilli J, Sibbing D, Siontis GCM, et al
    Questions and answers on antithrombotic therapy and revascularization strategies in non-ST-elevation acute coronary syndrome (NSTE-ACS): a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients present
    Eur Heart J. 2021;42:1368-1378.
    >> Share

  25. BARTHELEMY O, Jobs A, Meliga E, Mueller C, et al
    Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2021;42:1379-1386.
    >> Share

    March 2021
  26. FRIGERIO M
    Fausto Rovelli (1918-2021): the father of Italian cardiology, pioneer of early reperfusion therapy for acute myocardial infarction, and unforgettable master for his hospital colleagues.
    Eur Heart J. 2021 Mar 29. pii: 6199127. doi: 10.1093.
    >> Share

  27. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    >> Share

  28. ZHANG H, Xiao Z, Yang P, Hu J, et al
    Ruptured coronary artery aneurysm mimicking as a giant mediastinal mass.
    Eur Heart J. 2021;42:1183.
    >> Share

  29. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
    Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
    Eur Heart J. 2021;42:1019-1034.
    >> Share

  30. MARENZI G, Cosentino N, Cardinale D
    Ischaemic and bleeding risk in cancer patients undergoing PCI: another brick in the wall.
    Eur Heart J. 2021;42:1035-1037.
    >> Share

  31. ERDMANN J, van der Laan SW
    Unfolding and disentangling coronary vascular disease through genome-wide association studies.
    Eur Heart J. 2021;42:934-937.
    >> Share

  32. VAN DIEPEN S, Armstrong PW
    Learning whether to subtract beta-blockers: it's about time.
    Eur Heart J. 2021;42:915-918.
    >> Share

  33. IBANEZ B, Roque D, Price S
    The year in cardiovascular medicine 2020: acute coronary syndromes and intensive cardiac care.
    Eur Heart J. 2021;42:884-895.
    >> Share

  34. WANG X, Yan C
    Progression of artery aneurysm after transcatheter closure of coronary artery fistula.
    Eur Heart J. 2021;42:918.
    >> Share

    February 2021
  35. CEGLAREK U, Schellong P, Rosolowski M, Scholz M, et al
    The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
    Eur Heart J. 2021 Feb 27. pii: 6153946. doi: 10.1093.
    >> Share

  36. REFFO E, Stritoni V, Di Salvo G
    Inflammatory syndrome in children associated with COVID-19 complicated by acute myocardial infarction.
    Eur Heart J. 2021 Feb 20. pii: 6145783. doi: 10.1093.
    >> Share

  37. BOUABDALLAOUI N, Tardif JC
    Initiation of low-dose colchicine early after myocardial infarction.
    Eur Heart J. 2021 Feb 4. pii: 6127594. doi: 10.1093.
    >> Share

  38. HARTIALA JA, Han Y, Jia Q, Hilser JR, et al
    Genome-wide analysis identifies novel susceptibility loci for myocardial infarction.
    Eur Heart J. 2021 Feb 3. pii: 6126843. doi: 10.1093/eurheartj/ehaa1040.
    >> Share

  39. BERGONTI M
    Emergency Room visits in the COVID-19 pandemic.
    Eur Heart J. 2021;42:369-370.
    >> Share

    January 2021
  40. XING Y, Dai N, Li H
    Is abnormal function with troponin T elevation definitely myocardial infarction?
    Eur Heart J. 2021 Jan 30. pii: 6124030. doi: 10.1093.
    >> Share

  41. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    >> Share

  42. VRACHATIS DA, Giannopoulos GV, Deftereos SG
    Colchicine administered early in acute myocardial infarction: ready, set ... go?
    Eur Heart J. 2021 Jan 22. pii: 6106966. doi: 10.1093.
    >> Share


  43. Corrigendum to: Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2021;42:322.
    >> Share

  44. JOBS A, Collet JP, Thiele H
    Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data?
    Eur Heart J. 2021;42:353-354.
    >> Share

  45. KITE TA, Gershlick AH
    High-risk NSTE-ACS: high time for robust data.
    Eur Heart J. 2021;42:352.
    >> Share

  46. SCHRODER J, Michelsen MM, Mygind ND, Suhrs HE, et al
    Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study.
    Eur Heart J. 2021;42:228-239.
    >> Share

  47. RAY KK
    Changing the paradigm for post-MI cholesterol lowering from intensive statin monotherapy towards intensive lipid-lowering regimens and individualized care.
    Eur Heart J. 2021;42:253-256.
    >> Share

  48. DAVIES A, Fox K, Galassi AR, Banai S, et al
    Management of refractory angina: an update.
    Eur Heart J. 2021;42:269-283.
    >> Share

  49. SICARI R
    The curious incident of CFVR in clinical practice.
    Eur Heart J. 2021;42:240-242.
    >> Share

  50. PLAT J, Strandberg TE, Gylling H
    Intestinal cholesterol and phytosterol absorption and the risk of coronary artery disease.
    Eur Heart J. 2021;42:281-282.
    >> Share

  51. HELGADOTTIR A, Thorleifsson G, Stefansson K
    Increased absorption of phytosterols is the simplest and most plausible explanation for coronary artery disease risk not accounted for by non-HDL cholesterol in high cholesterol absorbers.
    Eur Heart J. 2021;42:283-284.
    >> Share

  52. ABDELWAHED YS, Wurster TH, Landmesser U, Leistner DM, et al
    Culprit mistaken: development of a traumatic coronary aneurysm after mismatched culprit lesion-PCI for plaque rupture.
    Eur Heart J. 2021;42:287.
    >> Share

  53. KOLBE M, Lopez-Ayala P, Mueller C
    Women who experience a myocardial infarction at a young age.
    Eur Heart J. 2021 Jan 19. pii: 6104220. doi: 10.1093.
    >> Share

  54. CHATTOPADHYAY S, John J
    Women experiencing myocardial infarction at a young age have worse outcomes compared with men: only for non-cardiovascular deaths and when treated inadequately?
    Eur Heart J. 2021 Jan 17. pii: 6103003. doi: 10.1093.
    >> Share

  55. HOLT A, Blanche P, Zareini B, Rajan D, et al
    Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study.
    Eur Heart J. 2021 Jan 11. pii: 6082772. doi: 10.1093/eurheartj/ehaa1058.
    >> Share

  56. MONACO C, Cole J
    Does a myocardial infarction boost your (B cell) memory?
    Eur Heart J. 2021 Jan 4. pii: 6061967. doi: 10.1093/eurheartj/ehaa1059.
    >> Share

  57. LIN S, Chen S, Zhe Z
    Model assessment: new measures should be known and traditional measures should be accurately interpreted.
    Eur Heart J. 2021;42:134-135.
    >> Share

  58. AMINORROAYA A, Tajdini M, Masoudkabir F
    Time for clinicians to revisit their perspectives on C-statistic.
    Eur Heart J. 2021;42:132-133.
    >> Share

  59. LAWLER PR, Bhatt DL, Godoy LC, Luscher TF, et al
    Targeting cardiovascular inflammation: next steps in clinical translation.
    Eur Heart J. 2021;42:113-131.
    >> Share

    December 2020
  60. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    >> Share

  61. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    >> Share

  62. FIOLET ATL, Nidorf SM, Cornel JH
    Colchicine for secondary prevention in coronary disease.
    Eur Heart J. 2020 Dec 21. pii: 6042608. doi: 10.1093.
    >> Share

  63. KYAW T, Loveland P, Kanellakis P, Cao A, et al
    Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.
    Eur Heart J. 2020 Dec 18. pii: 6041767. doi: 10.1093.
    >> Share

  64. KOTANIDIS CP, Antoniades C
    Selfies in cardiovascular medicine: welcome to a new era of medical diagnostics.
    Eur Heart J. 2020;41:4412-4414.
    >> Share

  65. ROY R, Koch WJ
    Adding another GRK to the fire of heart failure.
    Eur Heart J. 2020 Dec 7. pii: 6025474. doi: 10.1093.
    >> Share

  66. LI L, Fu W, Gong X, Chen Z, et al
    The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction.
    Eur Heart J. 2020 Dec 6. pii: 6024960. doi: 10.1093.
    >> Share

    November 2020
  67. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
    Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
    Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
    >> Share

  68. ORWAT S, Diller GP
    Congenital heart defects as an intrinsic additional risk factor for the occurrence and outcome of myocardial infarction.
    Eur Heart J. 2020 Nov 22. pii: 5998317. doi: 10.1093.
    >> Share

  69. FEDCHENKO M, Mandalenakis Z, Giang KW, Rosengren A, et al
    Long-term outcomes after myocardial infarction in middle-aged and older patients with congenital heart disease-a nationwide study.
    Eur Heart J. 2020 Nov 21. pii: 5997447. doi: 10.1093.
    >> Share

  70. MUNZEL T, Hahad O, Daiber A
    The dark side of nocturnal light pollution. Outdoor light at night increases risk of coronary heart disease.
    Eur Heart J. 2020 Nov 21. pii: 5998262. doi: 10.1093.
    >> Share

  71. BOHM M, Mahfoud F
    J-curve revisited.
    Eur Heart J. 2020;41:4283.
    >> Share

  72. LIEW CH, McEvoy JW
    The diastolic blood pressure J-curve remains an observational research phenomenon that has not yet been proven as causal and should not be used to make invasive treatment decisions.
    Eur Heart J. 2020;41:4284-4285.
    >> Share

  73. SUN S, Cao W, Ge Y, Ran J, et al
    Outdoor light at night and risk of coronary heart disease among older adults: a prospective cohort study.
    Eur Heart J. 2020 Nov 17. pii: 5986682. doi: 10.1093.
    >> Share

  74. ARSENOS P, Antoniou CK, Gatzoulis KA
    Risk stratification refinement and implantable cardioverter defibrillator protection for the coronary artery disease patients with a preserved left ventricular systolic function with a two-step programmed ventricular stimulation-inclusive approach.
    Eur Heart J. 2020 Nov 16. pii: 5983737. doi: 10.1093.
    >> Share

  75. NEUVILLERS L, Veugeois A, Didier J, Paul JF, et al
    Myocardial infarction with non-obstructive coronary artery revealing a heart tumour.
    Eur Heart J. 2020 Nov 13. pii: 5981589. doi: 10.1093.
    >> Share

  76. COLLET JP, Thiele H
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 13. pii: 5981490. doi: 10.1093.
    >> Share

  77. NICHOLLS M
    Australia and colchicine for coronary heart disease.
    Eur Heart J. 2020 Nov 10. pii: 5961660. doi: 10.1093.
    >> Share

  78. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
    >> Share

  79. LUSCHER TF
    The sooner, the better: anti-inflammation in acute myocardial infarction.
    Eur Heart J. 2020;41:4100-4102.
    >> Share

  80. VRACHATIS DA, Deftereos S, Stefanini GG
    STEMI in COVID-19 patients: thrombolysis-first approach could yield more risk than benefit.
    Eur Heart J. 2020;41:4141-4142.
    >> Share

  81. ZHANG L, Fan Y, Lu Z
    Compromised STEMI reperfusion strategy in the era of COVID-19 pandemic: pros and cons.
    Eur Heart J. 2020;41:4143.
    >> Share

  82. CANNON CP
    Chronic kidney disease: a high-risk group that deserves intensive lipid lowering.
    Eur Heart J. 2020;41:4124-4126.
    >> Share

  83. MELE M, Casavecchia G, Ieva R, Brunetti ND, et al
    Diagnosis of acute myocardial infarction in the time of the COVID-19 pandemic.
    Eur Heart J. 2020 Nov 4. pii: 5956256. doi: 10.1093.
    >> Share

    October 2020
  84. BATKAI S, Genschel C, Viereck J, Rump S, et al
    CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure.
    Eur Heart J. 2020 Oct 22. pii: 5934677. doi: 10.1093.
    >> Share

  85. LANDMESSER U, Luscher TF
    Advancing RNA-targeted therapy for personalised prevention of coronary disease: focus on ANGPLT3.
    Eur Heart J. 2020;41:3946-3948.
    >> Share

  86. TOKGOZOGLU L, Catapano AL
    Can EPA evaporate plaques?
    Eur Heart J. 2020;41:3933-3935.
    >> Share

  87. BALLANTYNE CM, Virani SS
    Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
    Eur Heart J. 2020;41:3910-3912.
    >> Share

  88. CHANDRASEKAR B, Alanbaei M
    Intracoronary imaging identifies plaque rupture underlying left main thrombosis in acute myocardial infarction without angiographically evident atherosclerosis.
    Eur Heart J. 2020 Oct 14. pii: 5922862. doi: 10.1093.
    >> Share

  89. BONNET M, Champagnac A, Lantelme P, Harbaoui B, et al
    Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.
    Eur Heart J. 2020;41:3863-3864.
    >> Share

  90. TWEET MS
    Sex differences among young individuals with myocardial infarction.
    Eur Heart J. 2020 Oct 13. pii: 5921646. doi: 10.1093.
    >> Share

  91. DEFILIPPIS EM, Collins BL, Singh A, Biery DW, et al
    Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry.
    Eur Heart J. 2020 Oct 13. pii: 5921645. doi: 10.1093.
    >> Share

  92. LIUZZO G, Patrono C
    Low-dose colchicine: a new tool in the treatment of chronic coronary disease? Comment on the low-dose colchicine (LoDoCo)2 trial.
    Eur Heart J. 2020 Oct 7. pii: 5918829. doi: 10.1093.
    >> Share

  93. BOLLI R
    Cell therapy for acute myocardial infarction: Requiescat in Pace.
    Eur Heart J. 2020;41:3711-3714.
    >> Share

  94. LANSKY A, Grubman D, Scheller B
    Paclitaxel-coated balloons: a safe alternative to drug-eluting stents for coronary in-stent restenosis.
    Eur Heart J. 2020;41:3729-3731.
    >> Share

  95. STOREY RF
    The long journey of individualizing antiplatelet therapy after acute coronary syndromes.
    Eur Heart J. 2020;41:3546-3548.
    >> Share

  96. LIUZZO G, Pedicino D, Vinci R, Crea F, et al
    CD8 lymphocytes and plaque erosion: a new piece in the jigsaw.
    Eur Heart J. 2020;41:3561-3563.
    >> Share

  97. BABER U, Dangas G, Angiolillo DJ, Cohen DJ, et al
    Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
    Eur Heart J. 2020;41:3533-3545.
    >> Share

    September 2020
  98. DORING Y, Noels H, van der Vorst E, Weber C, et al
    Seeing is repairing: how imaging-based timely interference with CXCR4 could improve repair after myocardial infarction.
    Eur Heart J. 2020 Sep 11. pii: 5904399. doi: 10.1093.
    >> Share

  99. HESS A, Derlin T, Koenig T, Diekmann J, et al
    Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4.
    Eur Heart J. 2020 Sep 9. pii: 5903166. doi: 10.1093.
    >> Share

  100. PARODI G, Sanna GD, Saba PS
    Understanding the complex interplay between coronary artery disease and Takotsubo syndrome: not all swans are white.
    Eur Heart J. 2020;41:3268-3270.
    >> Share

  101. SANZ-RUIZ R, Fernandez-Aviles F
    Cardiovascular regenerative and reparative medicine: is myocardial infarction the model?
    Eur Heart J. 2020 Sep 3. pii: 5900893. doi: 10.1093.
    >> Share

  102. LIBERALE L, Gorog DA
    Low-grade endotoxaemia and platelets: a deadly aggregation.
    Eur Heart J. 2020;41:3166-3168.
    >> Share

  103. SCHUPKE S, Kastrati A
    Mechanistic insights into the superior clinical efficacy of prasugrel over ticagrelor.
    Eur Heart J. 2020;41:3153-3155.
    >> Share

    August 2020
  104. MATHUR A, Fernandez-Aviles F, Bartunek J, Belmans A, et al
    The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial.
    Eur Heart J. 2020 Aug 30. pii: 5898841. doi: 10.1093.
    >> Share

  105. BOUABDALLAOUI N, Tardif JC, Waters DD, Pinto FJ, et al
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Eur Heart J. 2020 Aug 29. pii: 5898840. doi: 10.1093.
    >> Share

  106. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    >> Share

  107. TUNON J, Steg PG, Bhatt DL, Bittner VA, et al
    Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
    Eur Heart J. 2020 Aug 21. pii: 5895197. doi: 10.1093.
    >> Share

  108. KHAN S
    Mast cell tryptase level should be checked in all patients with suspected Kounis syndrome.
    Eur Heart J. 2020;41:3018.
    >> Share

  109. CHATTERJEE NA, Tikkanen JT, Albert CM
    The electrocardiogram and sudden death: capturing electrical physiology and arrhythmic substrate.
    Eur Heart J. 2020;41:2911-2912.
    >> Share

  110. ASATRYAN B, Roten L, Reichlin T
    Identifying coronary artery disease patients at risk for sudden and/or arrhythmic death: remaining limitations of the electrocardiogram.
    Eur Heart J. 2020;41:2911-2912.
    >> Share

    July 2020
  111. HARARI R, Bangalore S
    Beta-blockers after acute myocardial infarction: an old drug in urgent need of new evidence!
    Eur Heart J. 2020 Jul 30. pii: 5879119. doi: 10.1093.
    >> Share

  112. GILMANOV D, Greco C, Cafaro A, Zaccaria S, et al
    Two coronary artery aneurysms complicated by acute myocardial infarction and treated with open chest surgery.
    Eur Heart J. 2020 Jul 29. pii: 5877568. doi: 10.1093.
    >> Share

  113. WEINGARTNER O, Patel SB, Lutjohann D
    It's time to personalize and optimize lipid-lowering therapy.
    Eur Heart J. 2020;41:2629-2631.
    >> Share

  114. HOWARD JP, Arnold AD, Ahmad Y
    Bias, heterogeneity, and uncertainty in meta-analysis.
    Eur Heart J. 2020;41:2712.
    >> Share

  115. LI Y, Yan L, Shui S, Han X, et al
    Choriocarcinoma metastasis in the left atrium.
    Eur Heart J. 2020;41:2628.
    >> Share

  116. TAN HL, van Dongen LH, Zimmerman DS
    Sudden cardiac death in young patients with diabetes: a call to study additional causes beyond ischaemic heart disease.
    Eur Heart J. 2020;41:2707-2709.
    >> Share

  117. TU S, Westra J, Adjedj J, Wijns W, et al
    Physiological assessment of non-culprit stenoses during acute coronary syndromes.
    Eur Heart J. 2020;41:2598.
    >> Share

  118. BUENO H, Rossello X, Bardaji A
    Has the Fourth Universal Definition of Myocardial Infarction led to better diagnosis and risk stratification?
    Eur Heart J. 2020 Jul 10. pii: 5869541. doi: 10.1093.
    >> Share

  119. WACKER J, Malaspinas I, Aggoun Y, Bordessoule A, et al
    Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.
    Eur Heart J. 2020;41:3103.
    >> Share

    June 2020
  120. JAYARAJ R, Kumaraswamy C, Shaw P
    Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
    Eur Heart J. 2020 Jun 26. pii: 5863013. doi: 10.1093.
    >> Share

  121. STIEKEMA LCA, Hovingh GK, Stroes ESG
    The therapeutic age paradox coming to an end.
    Eur Heart J. 2020;41:2259-2261.
    >> Share

  122. KIM J, Kang D, Park H, Kang M, et al
    Long-term beta-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.
    Eur Heart J. 2020 Jun 15. pii: 5857797. doi: 10.1093.
    >> Share

  123. PAVASINI R, D'Ascenzo F, Campo G
    Moving forward from statistical to clinical considerations regarding complete revascularization.
    Eur Heart J. 2020;41:2225.
    >> Share

  124. JOBS A, Schwarzer G, Thiele H
    Conclusions of complete revascularization meta-analysis are challenged by state-of-the-art methods.
    Eur Heart J. 2020;41:2223-2224.
    >> Share

  125. THYGESEN K, Jaffe AS
    Our nearly complete diagnostic trip of thousands of steps begets a new trip therapeutically.
    Eur Heart J. 2020;41:2217-2219.
    >> Share

  126. KONDAPALLI L, Moslehi J, Bonaca MP
    Inflammation begets inflammation: cancer and acute MI.
    Eur Heart J. 2020;41:2194-2196.
    >> Share

  127. DUSI V, De Ferrari GM, Schwartz PJ
    There are 100 ways by which the sympathetic nervous system can trigger life-threatening arrhythmias.
    Eur Heart J. 2020;41:2180-2182.
    >> Share

  128. HUNG J, Roos A, Kadesjo E, McAllister DA, et al
    Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction.
    Eur Heart J. 2020 Jun 9. pii: 5855217. doi: 10.1093.
    >> Share

  129. ASHRAF S, Ilyas S, Alraies MC
    Acute coronary syndrome in the time of the COVID-19 pandemic.
    Eur Heart J. 2020;41:2089-2091.
    >> Share

  130. VALENTE S, Anselmi F, Cameli M
    Acute coronary syndromes during COVID-19.
    Eur Heart J. 2020;41:2047-2049.
    >> Share

  131. DOMINGUEZ-ERQUICIA P, Dobarro D, Raposeiras-Roubin S, Bastos-Fernandez G, et al
    Multivessel coronary thrombosis in a patient with COVID-19 pneumonia.
    Eur Heart J. 2020;41:2132.
    >> Share

  132. OLSHANSKY B
    The electrocardiogram: are we at the dawn of a new era?
    Eur Heart J. 2020;41:2000-2002.
    >> Share

    May 2020
  133. DE ROSA S, Spaccarotella C, Basso C, Calabro MP, et al
    Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.
    Eur Heart J. 2020 May 15. pii: 5837572. doi: 10.1093.
    >> Share

  134. CHIEFFO A, Stefanini GG, Price S, Barbato E, et al
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic.
    Eur Heart J. 2020;41:1839-1851.
    >> Share

  135. METZLER B, Siostrzonek P, Binder RK, Bauer A, et al
    Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage.
    Eur Heart J. 2020;41:1852-1853.
    >> Share

  136. CAMPO G, Rapezzi C, Tavazzi L, Ferrari R, et al
    Priorities for Cath labs in the COVID-19 tsunami.
    Eur Heart J. 2020;41:1784-1785.
    >> Share

  137. SHAH R
    Accuracy of fractional flow reserve during acute myocardial infarction.
    Eur Heart J. 2020 May 8. pii: 5834910. doi: 10.1093.
    >> Share

  138. UEKI Y, Otsuka T, Windecker S, Raber L, et al
    ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome.
    Eur Heart J. 2020 May 6. pii: 5831090. doi: 10.1093.
    >> Share

  139. GAUDINO M, Freemantle N, Farkouh ME
    The conundrum of the treatment for left main coronary disease.
    Eur Heart J. 2020 May 5. pii: 5830808. doi: 10.1093.
    >> Share

  140. BJORNSTAD JL, Bendz B
    Periprocedural myocardial injury in the EXCEL trial.
    Eur Heart J. 2020;41:1703.
    >> Share

  141. HESS CN, Hiatt WR
    Progress in the prevention and treatment of atherosclerotic cardiovascular disease: two steps forward, one step back.
    Eur Heart J. 2020;41:1650-1652.
    >> Share

    April 2020
  142. DREXLER M, Elsner C, Gabelmann V, Gori T, et al
    Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away.
    Eur Heart J. 2020 Apr 29. pii: 5826159. doi: 10.1093.
    >> Share

  143. HAN Y
    A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience.
    Eur Heart J. 2020 Apr 27. pii: 5825637. doi: 10.1093.
    >> Share

  144. ZULLO A, Lorenzetti R, Hassan C
    Is Escherichia coli involved in the myocardial infarction?
    Eur Heart J. 2020 Apr 16. pii: 5821041. doi: 10.1093.
    >> Share

  145. VIOLI F, Nocella C, Carnevale R
    Gut microbiota and myocardial infarction.
    Eur Heart J. 2020 Apr 16. pii: 5821053. doi: 10.1093.
    >> Share

  146. CHATTERJEE NA, Tikkanen JT, Panicker GK, Narula D, et al
    Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease.
    Eur Heart J. 2020 Apr 7. pii: 5817075. doi: 10.1093.
    >> Share

  147. LUSCHER TF
    Sex and gender and cardiovascular medicine: impact in diabetes, acute coronary syndromes, and heart failure.
    Eur Heart J. 2020;41:1311-1314.
    >> Share

    March 2020
  148. JING ZC, Zhu HD, Yan XW, Chai WZ, et al
    Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak.
    Eur Heart J. 2020 Mar 31. pii: 5813956. doi: 10.1093.
    >> Share

  149. STONE GW, Ben-Yehuda O, Sabik JF, Kappetein AP, et al
    Considerations for an optimal definition of procedural myocardial infarction.
    Eur Heart J. 2020 Mar 30. pii: 5813684. doi: 10.1093.
    >> Share

  150. BOHM M, Ferreira JP, Mahfoud F, Duarte K, et al
    Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial.
    Eur Heart J. 2020 Mar 2. pii: 5771273. doi: 10.1093.
    >> Share

  151. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
    The muddy waters of the J-curve and coronary revascularization.
    Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
    >> Share

  152. KIM WC, Sumaya W, Elkhateeb OE
    Fibroelastoma presenting with recurrent myocardial infarction and diagnosed with intracoronary imaging: a novel intracoronary image of fibroelastoma.
    Eur Heart J. 2020 Mar 2. pii: 6157022. doi: 10.1093.
    >> Share

  153. AHMAD Y, Howard JP, Arnold AD, Cook CM, et al
    Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2020 Mar 2. pii: 5771278. doi: 10.1093.
    >> Share

  154. KLEBER ME, Delgado GE, Marz W
    LDL receptor traffic: in the fast lane.
    Eur Heart J. 2020;41:1054-1056.
    >> Share

    February 2020
  155. HARTIKAINEN TS, Sorensen NA, Haller PM, Gossling A, et al
    Clinical application of the 4th Universal Definition of Myocardial Infarction.
    Eur Heart J. 2020 Feb 20. pii: 5741381. doi: 10.1093.
    >> Share

  156. ALLAHYARI A, Jernberg T, Hagstrom E, Leosdottir M, et al
    Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.
    Eur Heart J. 2020 Feb 18. pii: 5739477. doi: 10.1093.
    >> Share

  157. LABRECQUE JA, Kaufman JS, Huang JY
    Genetic instruments with too many strings: acknowledging pleiotropy and population structure in Mendelian randomization studies.
    Eur Heart J. 2020;41:892-893.
    >> Share

  158. SINNAEVE P, Van de Werf F
    Primary PCI and the indistinct 120 min time limit.
    Eur Heart J. 2020;41:867-869.
    >> Share

  159. RYMER JA, Granger CB
    Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?
    Eur Heart J. 2020 Feb 7. pii: 5729984. doi: 10.1093.
    >> Share

  160. RAMASAMY A, Bajaj R, Choudry FA, Pugliese F, et al
    Intravascular ultrasound-guided management of ST-elevation myocardial infarction in a patient with lung cancer and myocardial metastasis.
    Eur Heart J. 2020 Feb 7. pii: 5729982. doi: 10.1093.
    >> Share

  161. GIANNOPOULOS AA, Gaemperli O
    The power of myocardial blood flow reserve in personalizing management of patients with stable coronary artery disease. Is it time to move on from percentage of ischaemia?
    Eur Heart J. 2020;41:769-771.
    >> Share

    January 2020
  162. KALLISTRATOS MS, Poulimenos LE, Manolis AJ
    Beta blockers, calcium channel blockers, and long-acting nitrates for patients with stable angina and low blood pressure levels: should this recommendation be reconsidered?
    Eur Heart J. 2020;41:479.
    >> Share

  163. KNUUTI J, Wijns W, Funck-Brentano C
    Anti-ischaemic medication must be adapted to each patient's characteristics and preferences in patients with chronic coronary syndromes.
    Eur Heart J. 2020;41:480-481.
    >> Share

  164. SENGUPTA PP, Shrestha S, Zeb I
    Solving coronary risk: time to feed machines some calcium (score) supplements.
    Eur Heart J. 2020;41:368-370.
    >> Share

  165. POSS AM, Holland WL, Summers SA
    Risky lipids: refining the ceramide score that measures cardiovascular health.
    Eur Heart J. 2020;41:381-382.
    >> Share

  166. LUSCHER TF
    Chronic coronary syndromes: expanding the spectrum and natural history of ischaemic heart disease.
    Eur Heart J. 2020;41:333-336.
    >> Share

  167. IANNACCONE M, Brilakis ES, Boccuzzi GG
    An App for complex PCI solutions.
    Eur Heart J. 2020;41:342-344.
    >> Share

  168. AL'AREF SJ, Maliakal G, Singh G, van Rosendael AR, et al
    Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry.
    Eur Heart J. 2020;41:359-367.
    >> Share

  169. KNUUTI J, Wijns W, Saraste A, Capodanno D, et al
    2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
    Eur Heart J. 2020;41:407-477.
    >> Share

  170. SORBETS E, Fox KM, Elbez Y, Danchin N, et al
    Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.
    Eur Heart J. 2020;41:347-356.
    >> Share

  171. PRATI F, Romagnoli E, Gatto L, La Manna A, et al
    Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study.
    Eur Heart J. 2020;41:383-391.
    >> Share

  172. HILVO M, Meikle PJ, Pedersen ER, Tell GS, et al
    Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
    Eur Heart J. 2020;41:371-380.
    >> Share

  173. ALI ZA, McEntegart M, Hill JM, Spratt JC, et al
    Intravascular lithotripsy for treatment of stent underexpansion secondary to severe coronary calcification.
    Eur Heart J. 2020;41:485-486.
    >> Share

  174. LEE HS, Chang M, Piccinelli M, Koo BK, et al
    Complete regression of coronary atherosclerosis.
    Eur Heart J. 2020;41:332.
    >> Share

  175. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
    The year in cardiology: coronary interventions.
    Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
    >> Share

  176. CARNEVALE R, Sciarretta S, Valenti V, di Nonno F, et al
    Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction.
    Eur Heart J. 2020 Jan 3. pii: 5695525. doi: 10.1093.
    >> Share

  177. SCHNORBUS B, Daiber A, Jurk K, Warnke S, et al
    Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study.
    Eur Heart J. 2020 Jan 3. pii: 5695774. doi: 10.1093.
    >> Share

    December 2019
  178. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
    Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
    >> Share

  179. LANCINI D, Shetty R
    Tension pneumothorax: a Brugada phenocopy and ST-elevation myocardial infarction mimic.
    Eur Heart J. 2019 Dec 28. pii: 5688935. doi: 10.1093.
    >> Share

  180. WELSH RC
    Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
    Eur Heart J. 2019 Dec 23. pii: 5686009. doi: 10.1093.
    >> Share

  181. KOGAME N, Serruys PW, Onuma Y
    Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.
    Eur Heart J. 2019 Dec 23. pii: 5686015. doi: 10.1093.
    >> Share

  182. MALMBORG M, Schmiegelow MDS, Norgaard CH, Munch A, et al
    Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
    Eur Heart J. 2019 Dec 20. pii: 5682397. doi: 10.1093.
    >> Share

  183. ROEVER L, Tse G, Versaci F, Biondi-Zoccai G, et al
    Admission glucagon-like peptide-1 levels in acute myocardial infarction: is this a new biomarker of cardiovascular risk?
    Eur Heart J. 2019 Dec 13. pii: 5675546. doi: 10.1093.
    >> Share

  184. KALLA M, Hao G, Tapoulal N, Tomek J, et al
    The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.
    Eur Heart J. 2019 Dec 13. pii: 5675548. doi: 10.1093.
    >> Share

  185. FURTADO RHM, Nicolau JC, Magnani G, Im K, et al
    Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2019 Dec 7. pii: 5663567. doi: 10.1093.
    >> Share

  186. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    >> Share

  187. LOPEZ-JIMENEZ F, Gersh BJ
    Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
    Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
    >> Share

    November 2019
  188. LOPES RD, Hong H, Alexander JH
    Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
    Eur Heart J. 2019 Nov 27. pii: 5644218. doi: 10.1093.
    >> Share

  189. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
    Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
    Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
    >> Share

  190. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    >> Share

  191. SINNAEVE PR, Schwartz GG, Wojdyla DM, Alings M, et al
    Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
    Eur Heart J. 2019 Nov 16. pii: 5626150. doi: 10.1093.
    >> Share

    October 2019
  192. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    >> Share

  193. BJORKLUND E, Nielsen SJ, Hansson EC, Karlsson M, et al
    Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
    Eur Heart J. 2019 Oct 22. pii: 5602556. doi: 10.1093.
    >> Share

  194. RIMBERT A, Dalila N, Wolters JC, Huijkman N, et al
    A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.
    Eur Heart J. 2019 Oct 19. pii: 5599853. doi: 10.1093.
    >> Share

  195. KAHLES F, Ruckbeil MV, Mertens RW, Foldenauer AC, et al
    Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.
    Eur Heart J. 2019 Oct 16. pii: 5588525. doi: 10.1093.
    >> Share

  196. IBANEZ B
    And fibrinolysis became pharmacoinvasive.
    Eur Heart J. 2019 Oct 12. pii: 5586502. doi: 10.1093.
    >> Share

    September 2019
  197. DANCHIN N, Popovic B, Puymirat E, Goldstein P, et al
    Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.
    Eur Heart J. 2019 Sep 20. pii: 5572227. doi: 10.1093.
    >> Share

  198. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
    16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
    >> Share

  199. MUKHERJEE D
    Tailoring strategies to optimize ischaemic benefit vs. bleeding risk in individuals post-myocardial infarction.
    Eur Heart J. 2019 Sep 1. pii: 5555736. doi: 10.1093.
    >> Share

  200. SIMONSSON M, Wallentin L, Alfredsson J, Erlinge D, et al
    Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry.
    Eur Heart J. 2019 Sep 1. pii: 5554428. doi: 10.1093.
    >> Share

    August 2019
  201. TAYAL B, Fruelund P, Sogaard P, Riahi S, et al
    Incidence of heart failure after pacemaker implantation: a nationwide Danish Registry-based follow-up study.
    Eur Heart J. 2019 Aug 26. pii: 5554632. doi: 10.1093.
    >> Share

  202. LUSCHER TF
    Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.
    Eur Heart J. 2019;40:2549-2552.
    >> Share

  203. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    >> Share

  204. CREA F, Montone RA, Niccoli G
    Myocardial infarction with non-obstructive coronary atherosclerosis: dealing with pears and apples.
    Eur Heart J. 2019 Aug 3. pii: 5543490. doi: 10.1093.
    >> Share

  205. MAGGIONI AP, Andreotti F
    Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?
    Eur Heart J. 2019 Aug 1. pii: 5542639. doi: 10.1093.
    >> Share

    July 2019
  206. ODER D, Topp MS, Nordbeck P
    Coronary B-cell lymphoma infiltration causing myocardial infarction.
    Eur Heart J. 2019 Jul 31. pii: 5542062. doi: 10.1093.
    >> Share

  207. FRANGOGIANNIS NG
    S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges.
    Eur Heart J. 2019 Jul 23. pii: 5537337. doi: 10.1093.
    >> Share

  208. MARINKOVIC G, Grauen Larsen H, Yndigegn T, Szabo IA, et al
    Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.
    Eur Heart J. 2019 Jul 10. pii: 5530698. doi: 10.1093.
    >> Share

  209. THIELE H, Ohman EM, de Waha-Thiele S, Zeymer U, et al
    Management of cardiogenic shock complicating myocardial infarction: an update 2019.
    Eur Heart J. 2019 Jul 4. pii: 5528526. doi: 10.1093.
    >> Share

    June 2019

  210. Corrigendum to: Ephemeral Coronary Heart Disease.
    Eur Heart J. 2019 Jun 29. pii: 5530690. doi: 10.1093.
    >> Share

  211. THYGESEN K, Jaffe AS
    Should myocardial infarction type 2 be regarded as two separate entities?
    Eur Heart J. 2019 Jun 26. pii: 5523696. doi: 10.1093.
    >> Share

  212. MEHRA MR, Vaduganathan M, Fu M, Ferreira JP, et al
    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
    Eur Heart J. 2019 Jun 25. pii: 5522950. doi: 10.1093.
    >> Share

  213. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    >> Share

  214. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    >> Share

  215. MESSERLI FH
    Ephemeral Coronary Heart Disease.
    Eur Heart J. 2019;40:1906-1908.
    >> Share

  216. DREYER RP, Tavella R, Curtis JP, Wang Y, et al
    Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.
    Eur Heart J. 2019 Jun 21. pii: 5521361. doi: 10.1093.
    >> Share

  217. WHITE HD
    Adjunctive antithrombotic therapy with primary percutaneous coronary intervention in ST elevation myocardial infarction: ATOLL in perspective.
    Eur Heart J. 2019;40:e4-e7.
    >> Share

  218. ZENG L, Ntalla I, Kessler T, Kastrati A, et al
    Genetically modulated educational attainment and coronary disease risk.
    Eur Heart J. 2019 Jun 6. pii: 5512096. doi: 10.1093.
    >> Share

  219. LI Z, Solomonidis EG, Meloni M, Taylor RS, et al
    Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510786. doi: 10.1093.
    >> Share

  220. ROHDE D, Nahrendorf M
    Clonal and diverse: revisiting cardiac endothelial cells after myocardial infarction.
    Eur Heart J. 2019 Jun 4. pii: 5510784. doi: 10.1093.
    >> Share

  221. GENTILLE LORENTE DI
    Coconut atrium: a rare entity to cause pulmonary hypertension.
    Eur Heart J. 2019 Jun 4. pii: 5510776. doi: 10.1093.
    >> Share

    May 2019
  222. LEMKES JS, Janssens GN, van Royen N
    ST-resolution and spontaneous reperfusion in patients with transient ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 May 29. pii: 5506052. doi: 10.1093.
    >> Share

  223. WHITE HD, Steg PG, Szarek M, Bhatt DL, et al
    Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
    Eur Heart J. 2019 May 23. pii: 5497814. doi: 10.1093.
    >> Share

  224. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
    Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
    Eur Heart J. 2019 May 22. pii: 5492739. doi: 10.1093.
    >> Share

  225. DEVEREAUX PJ, Szczeklik W
    Myocardial injury after non-cardiac surgery: diagnosis and management.
    Eur Heart J. 2019 May 16. pii: 5490290. doi: 10.1093.
    >> Share

  226. NISHI T, Funabashi N, Fujimoto Y, Kobayashi Y, et al
    Simultaneous anterior and inferior myocardial infarction in a patient with a single coronary artery anomaly.
    Eur Heart J. 2019 May 3. pii: 5485104. doi: 10.1093.
    >> Share

  227. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    >> Share

    April 2019
  228. HU C, Tkebuchava T, Hu D
    Managing acute myocardial infarction in China.
    Eur Heart J. 2019;40:1179-1181.
    >> Share

  229. JONES DA, Rathod KS, Koganti S, Lim P, et al
    The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention: an observational study from the Pan-London PCI (BCIS) Registry using an
    Eur Heart J. 2019 Apr 10. pii: 5443278. doi: 10.1093.
    >> Share

  230. MEHRAN R, Kalkman DN, Angiolillo DJ
    Atrial fibrillation, with ACS and PCI: walking a tightrope.
    Eur Heart J. 2019 Apr 8. pii: 5431179. doi: 10.1093.
    >> Share

    March 2019
  231. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
    Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
    >> Share

  232. GRABHER F, Hamm W, Massberg S, Orban M, et al
    Uncommon cause of progressive dyspnoea 12 years after coronary artery bypass surgery.
    Eur Heart J. 2019 Mar 12. pii: 5377349. doi: 10.1093.
    >> Share

  233. HERRING N, Tapoulal N, Kalla M, Ye X, et al
    Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction.
    Eur Heart J. 2019 Mar 11. pii: 5374846. doi: 10.1093.
    >> Share

  234. CHEN K, Breitner S, Wolf K, Hampel R, et al
    Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987-2014.
    Eur Heart J. 2019 Mar 11. pii: 5374842. doi: 10.1093.
    >> Share

  235. YOSHIDA R, Takagi K, Morita Y, Morishima I, et al
    Incidentally discovered left ventricular pseudoaneurysm after silent myocardial infarction occurred in a young woman with peritoneal dialysis.
    Eur Heart J. 2019 Mar 11. pii: 5374728. doi: 10.1093.
    >> Share

  236. SEHESTED TSG, Carlson N, Hansen PW, Gerds TA, et al
    Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.
    Eur Heart J. 2019 Mar 9. pii: 5372329. doi: 10.1093.
    >> Share

  237. REDFORS B, Dworeck C, Haraldsson I, Angeras O, et al
    Pretreatment with P2Y12 receptor antagonists in ST-elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Eur Heart J. 2019 Mar 9. pii: 5372330. doi: 10.1093.
    >> Share

  238. RABER L, Yamaji K, Kelbaek H, Engstrom T, et al
    Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial inf
    Eur Heart J. 2019 Mar 9. pii: 5372331. doi: 10.1093.
    >> Share

    February 2019
  239. HECHT HS, Shaw L, Chandrashekhar YS, Bax JJ, et al
    Should NICE guidelines be universally accepted for the evaluation of stable coronary disease? A debate.
    Eur Heart J. 2019 Feb 27. pii: 5366197. doi: 10.1093.
    >> Share

  240. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
    >> Share

  241. WITASSEK F, Radovanovic D, Erne P, Puhan M, et al
    Mortality with antidepressants after acute MI: Antidepressant use after acute myocardial infarction (MI) is associated with an increased mortality 1 year after discharge from Swiss hospitals.
    Eur Heart J. 2019;40:410.
    >> Share

    January 2019
  242. CHEN S, Stone GW
    Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction.
    Eur Heart J. 2019 Jan 30. pii: 5304404. doi: 10.1093.
    >> Share

  243. WU J, Hall M, Dondo TB, Wilkinson C, et al
    Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.
    Eur Heart J. 2019 Jan 29. pii: 5301310. doi: 10.1093.
    >> Share

  244. VACCARINO V, Badimon L, Bremner JD, Cenko E, et al
    Depression and coronary heart disease: 2018 ESC position paper of the working group of coronary pathophysiology and microcirculation developed under the auspices of the ESC Committee for Practice Guidelines.
    Eur Heart J. 2019 Jan 28. pii: 5303703. doi: 10.1093.
    >> Share

  245. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    >> Share

  246. THYGESEN K
    'Ten Commandments' for the Fourth Universal Definition of Myocardial Infarction 2018.
    Eur Heart J. 2019;40:226.
    >> Share

  247. CREA F, Bairey Merz CN, Beltrame JF, Berry C, et al
    Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
    Eur Heart J. 2019 Jan 4. pii: 5273474. doi: 10.1093.
    >> Share

  248. DUDEK D, Dziewierz A, Stone G, Wijns W, et al
    The year in cardiology 2018: coronary interventions.
    Eur Heart J. 2019 Jan 2. pii: 5265297. doi: 10.1093.
    >> Share

    December 2018
  249. ZIMMERMANN FM, Omerovic E, Fournier S, Kelbaek H, et al
    Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
    Eur Heart J. 2018 Dec 28. pii: 5265290. doi: 10.1093.
    >> Share

  250. LUSCHER TF
    Personalized approaches to heart failure: age, acute presentation, and comorbidities.
    Eur Heart J. 2018;39:4223-4226.
    >> Share

  251. RESOR CD, Bhatt DL
    Bioresorbable vascular scaffolds in acute myocardial infarction: non-inferior or not enough data?
    Eur Heart J. 2018 Dec 18. pii: 5251899. doi: 10.1093.
    >> Share

  252. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    >> Share

    November 2018
  253. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
    Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
    Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
    >> Share

  254. SHARMA S, Malhotra A
    Exercise testing and coronary disease: pushing fitness to higher peaks.
    Eur Heart J. 2018 Nov 29. pii: 5193507. doi: 10.1093.
    >> Share

  255. LETNES JM, Dalen H, Vesterbekkmo EK, Wisloff U, et al
    Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study.
    Eur Heart J. 2018 Nov 29. pii: 5193503. doi: 10.1093.
    >> Share

  256. XIN Y, Chen X, Hu W
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Nov 28. pii: 5212709. doi: 10.1093.
    >> Share

  257. POLIMENI A, Spaccarotella C, Mongiardo A, Indolfi C, et al
    Myocardial infarction after dog bite.
    Eur Heart J. 2018 Nov 28. pii: 5212711. doi: 10.1093.
    >> Share

  258. BERGMARK BA, Faxon DP
    Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome?
    Eur Heart J. 2018 Nov 15. pii: 5184544. doi: 10.1093.
    >> Share

  259. THYGESEN K
    What's new in the Fourth Universal Definition of Myocardial infarction?
    Eur Heart J. 2018;39:3757-3758.
    >> Share

  260. ELNABAWI YA, Dey AK, Mehta NN
    Emerging Applications of Coronary CT Angiography in Coronary Heart Disease: Getting Better with Time.
    Eur Heart J. 2018;39:3682-3684.
    >> Share

    October 2018
  261. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    >> Share

  262. LEMKES JS, Janssens GN, van der Hoeven NW, van de Ven PM, et al
    Timing of revascularization in patients with transient ST-segment elevation myocardial infarction: a randomized clinical trial.
    Eur Heart J. 2018 Oct 26. pii: 5145843. doi: 10.1093.
    >> Share

  263. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
    Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
    >> Share

  264. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
    A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
    Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
    >> Share

  265. WALLENTIN L
    Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
    Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
    >> Share

    September 2018
  266. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    >> Share

  267. STONE GW, Genereux P, Harrington RA, White HD, et al
    Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
    Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
    >> Share

  268. HALL M, Bebb OJ, Dondo TB, Yan AT, et al
    Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction.
    Eur Heart J. 2018 Sep 7. pii: 5092654. doi: 10.1093.
    >> Share

  269. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Reconsidering aetiologies of type 2 myocardial infarction: when a classification is a simplistic approach for a complex reality.
    Eur Heart J. 2018 Sep 6. pii: 5091846. doi: 10.1093.
    >> Share

  270. NESTELBERGER T, Boeddinghaus J, Mueller C
    Type 2 myocardial infarction.
    Eur Heart J. 2018 Sep 6. pii: 5091844. doi: 10.1093.
    >> Share

    August 2018
  271. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Neumann JT, et al
    Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction.
    Eur Heart J. 2018 Aug 29. pii: 5086724. doi: 10.1093.
    >> Share

  272. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth universal definition of myocardial infarction (2018).
    Eur Heart J. 2018 Aug 25. pii: 5079081. doi: 10.1093.
    >> Share

  273. WINDECKER S, Neumann FJ, Juni P, Sousa-Uva M, et al
    Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of th
    Eur Heart J. 2018 Aug 25. pii: 5077827. doi: 10.1093.
    >> Share

  274. SHIMONO H, Kajiya T, Atsuchi Y, Atsuchi N, et al
    Giant left ventricular pseudo-aneurysm after posterior myocardial infarction.
    Eur Heart J. 2018 Aug 21. pii: 5077320. doi: 10.1093.
    >> Share

  275. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
    Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
    Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
    >> Share

  276. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
    Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
    >> Share

  277. O'SHAUGHNESSY MM, Liu S, Montez-Rath ME, Lafayette RA, et al
    Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
    Eur Heart J. 2018 Aug 2. pii: 5064050. doi: 10.1093.
    >> Share

    July 2018
  278. VARENNE O, Sinnaeve PR
    De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
    >> Share

  279. LUSCHER TF
    Performance of modern stents in stable and acute coronary disease.
    Eur Heart J. 2018;39:2435-2438.
    >> Share

    June 2018
  280. SAITO S, Krucoff MW, Nakamura S, Mehran R, et al
    Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-elu
    Eur Heart J. 2018 Jun 21. pii: 5042208. doi: 10.1093.
    >> Share

  281. HOFMANN R, Witt N, Lagerqvist B, Jernberg T, et al
    Oxygen therapy in ST-elevation myocardial infarction.
    Eur Heart J. 2018 Jun 14. pii: 5037999. doi: 10.1093.
    >> Share

  282. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Eur Heart J. 2018;39:2192-2207.
    >> Share

    May 2018
  283. MONTONE RA, Niccoli G, Lanza GA, Crea F, et al
    Personalized treatment of myocardial infarction and non-obstructive coronary arteries: an unmet need in a high-risk population.
    Eur Heart J. 2018 May 29. pii: 5020746. doi: 10.1093.
    >> Share

  284. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    >> Share

  285. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    >> Share

  286. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
    Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
    Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
    >> Share

    April 2018
  287. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    >> Share

    March 2018
  288. WALDMANN V, Bougouin W, Karam N, Dumas F, et al
    Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
    Eur Heart J. 2018 Mar 16. pii: 4939309. doi: 10.1093.
    >> Share

  289. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    >> Share

  290. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    >> Share

    February 2018
  291. THYGESEN K, Jaffe AS
    The prognostic impact of periprocedural myocardial infarction and injury.
    Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
    >> Share

  292. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
    >> Share


  293. euro6.5 million award to study impact of ECMO on myocardial infarction patients.
    Eur Heart J. 2018;39:649.
    >> Share

  294. WIJNS W, Naber CK
    Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
    Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
    >> Share

  295. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    >> Share

    January 2018
  296. BERGMARK BA, Scirica BM, Steg PG, Fanola CL, et al
    Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
    Eur Heart J. 2018 Jan 31. pii: 4831245. doi: 10.1093.
    >> Share

  297. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    >> Share

  298. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
    Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
    >> Share

  299. LUSCHER TF
    ST-segment elevation myocardial infarction: the new ESC Guidelines.
    Eur Heart J. 2018;39:75-78.
    >> Share

  300. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    >> Share

    December 2017
  301. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
    Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
    Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
    >> Share

  302. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
    Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
    Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
    >> Share

    November 2017
  303. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    >> Share

  304. LUSCHER TF
    Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
    Eur Heart J. 2017;38:3109-3113.
    >> Share

    October 2017
  305. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    >> Share

  306. THYGESEN K, Jaffe AS
    Detecting myocardial infarction type 2: targetting the right patients.
    Eur Heart J. 2017 Oct 5. doi: 10.1093.
    >> Share

  307. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
    Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
    Eur Heart J. 2017 Oct 3. doi: 10.1093.
    >> Share

    September 2017
  308. LEU HB, Chang HH, Lin SM, Chen YH, et al
    Double trouble for transcatheter aortic valve implantation: a patient with no vascular access and high-risk features for bilateral coronary obstruction.
    Eur Heart J. 2017;38:2787.
    >> Share

  309. KIVIMAKI M, Nyberg ST, Batty GD, Kawachi I, et al
    Long working hours as a risk factor for atrial fibrillation: a multi-cohort study.
    Eur Heart J. 2017;38:2621-2628.
    >> Share

    August 2017
  310. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    >> Share

  311. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    >> Share

  312. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    >> Share

  313. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    >> Share

  314. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
    Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    >> Share

  315. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
    Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    >> Share

  316. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
    Discrimination of patients with type 2 myocardial infarction.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    >> Share

  317. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    >> Share

  318. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
    Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
    Eur Heart J. 2017 Aug 7. doi: 10.1093.
    >> Share

    July 2017
  319. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    >> Share

  320. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    >> Share

  321. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    >> Share

  322. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
    Infections, atherosclerosis, and coronary heart disease.
    Eur Heart J. 2017 Jul 12. doi: 10.1093.
    >> Share

    May 2017
  323. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    >> Share

    April 2017
  324. SINGH-MANOUX A, Fayosse A, Sabia S, Canonico M, et al
    Atrial fibrillation as a risk factor for cognitive decline and dementia.
    Eur Heart J. 2017 Apr 29. doi: 10.1093.
    >> Share

  325. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    >> Share

  326. GABET A, Danchin N, Juilliere Y, Olie V, et al
    Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
    Eur Heart J. 2017;38:1060-1065.
    >> Share

  327. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    >> Share

  328. GEBHARD C
    Women and acute coronary syndromes: still up to no good.
    Eur Heart J. 2017;38:1066-1068.
    >> Share

  329. ONUMA Y, Serruys PW
    Freedom from long DAPT signals the demise of the bare-metal stent.
    Eur Heart J. 2017;38:970-973.
    >> Share

  330. CARLSSON M
    The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
    Eur Heart J. 2017;38:999-1001.
    >> Share

    March 2017
  331. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    >> Share

  332. JIA H, Dai J, Hou J, Xing L, et al
    Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
    Eur Heart J. 2017;38:792-800.
    >> Share

    February 2017
  333. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    >> Share

  334. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
    ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Eur Heart J. 2017;38:586-594.
    >> Share

  335. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
    Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
    Eur Heart J. 2017;38:598-608.
    >> Share

  336. SHUN-SHIN MJ, Zheng SL, Cole GD, Howard JP, et al
    Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.
    Eur Heart J. 2017 Feb 21. doi: 10.1093.
    >> Share

  337. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
    The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
    Eur Heart J. 2017 Feb 15. doi: 10.1093.
    >> Share

  338. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
    Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
    Eur Heart J. 2017;38:489-496.
    >> Share

  339. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
    Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
    Eur Heart J. 2017;38:516-523.
    >> Share

  340. MOTWANI M, Dey D, Berman DS, Germano G, et al
    Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
    Eur Heart J. 2017;38:500-507.
    >> Share

  341. PRIES AR, Reglin B
    Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
    Eur Heart J. 2017;38:478-488.
    >> Share

  342. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    >> Share

  343. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
    Increased haematopoietic activity in patients with atherosclerosis.
    Eur Heart J. 2017;38:425-432.
    >> Share

  344. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
    Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
    Eur Heart J. 2017;38:400-412.
    >> Share

  345. LEIPSIC J, Blanke P
    Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
    Eur Heart J. 2017;38:422-424.
    >> Share

  346. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    >> Share

    December 2016
  347. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
    Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
    >> Share

  348. PELLICANO M, De Bruyne B, Toth GG, Casselman F, et al
    Fractional flow reserve to guide and to assess coronary artery bypass grafting.
    Eur Heart J. 2016 Dec 23. pii: ehw505. doi: 10.1093.
    >> Share

    November 2016
  349. RYAN N, Escaned J
    Myocardial bridge as a cause of persistent post percutaneous coronary intervention angina identified with exercise intracoronary physiology.
    Eur Heart J. 2016.
    >> Share

    October 2016
  350. CREA F, Bairey Merz CN, Beltrame JF, Kaski JC, et al
    The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift.
    Eur Heart J. 2016.
    >> Share

  351. ALFONSO F, Rivero F
    Coronary revascularization in diabetic patients with chronic kidney disease.
    Eur Heart J. 2016.
    >> Share

    September 2016
  352. JORGE C, Hiltrop N, Desmet W
    Heart failure with preserved ejection fraction: blame the veins....
    Eur Heart J. 2016.
    >> Share

  353. KOYAMA M, Yano T, Kikuchi K, Nagahara D, et al
    Lethal heart failure with anti-mitochondrial antibody: an arrhythmogenic right ventricular cardiomyopathy mimetic.
    Eur Heart J. 2016.
    >> Share

    August 2016
  354. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
    Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
    Eur Heart J. 2016.
    >> Share

  355. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
    Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Eur Heart J. 2016.
    >> Share

  356. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
    The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
    Eur Heart J. 2016.
    >> Share

    June 2016
  357. HEIDBUCHEL H, Verhamme P, Alings M, Antz M, et al
    Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary.
    Eur Heart J. 2016.
    >> Share

    May 2016
  358. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    >> Share

    April 2016
  359. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
    Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
    Eur Heart J. 2016.
    >> Share

    February 2016
  360. DIENER HC, Aisenberg J, Ansell J, Atar D, et al
    Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
    Eur Heart J. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016